Molecure filings
Current reports and announcements from Molecure (MOC), newest first. Filings published on the company's investor-relations site carry a short AI summary based only on the filing text.
- Otrzymanie rekomendacji kontynuacji badania Fazy II dla cząsteczki OATD-01 u pacjentów z aktywną sarkoidozą płucną.
FilingParkiet
This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.